Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most-Timing or Donor Source?

作者:Bhatia Monica; Lee Matthew; Costa Katherine; Jin Zhezhen; Karamehmet Esra; Garvin James; George Diane; Kung Andrew; Dvorak Christopher C; Horn Biljana; Satwani Prakash
来源:BMT Tandem Meetings, 2015-02-11 to 2015-02-15.
  • 出版日期2015-2